Literature DB >> 15474111

Intratympanic steroids for sensorineural hearing loss.

Steven D Rauch1.   

Abstract

Corticosteroids are standard treatment for a number of inflammatory and immune-mediated inner ear diseases. In recent years there has been growing interest in intratympanic administration of steroids as a means of achieving high inner ear drug concentration and low risk of systemic side effects. Idiopathic sudden sensorineural hearing loss seems to be the condition with the greatest potential for both study and clinical use of intratympanic steroid treatment. Despite promising preliminary observations, there re-main many unanswered questions about this treatment modality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474111     DOI: 10.1016/j.otc.2004.04.004

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  21 in total

1.  Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.

Authors:  Young Ho Kim; Kyung Tae Park; Byung Yoon Choi; Min Hyun Park; Jun Ho Lee; Seung-Ha Oh; Sun O Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-08       Impact factor: 2.503

Review 2.  Immune cells and non-immune cells with immune function in mammalian cochleae.

Authors:  Bo Hua Hu; Celia Zhang; Mitchell D Frye
Journal:  Hear Res       Date:  2017-12-20       Impact factor: 3.208

Review 3.  Principles of local drug delivery to the inner ear.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

4.  Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

5.  Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.

Authors:  Yao-wen Wang; Ji-hao Ren; Yong-de Lu; Tuan-fang Yin; Ding-hua Xie
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

6.  Transtympanic steroids in refractory sudden hearing loss. Personal experience.

Authors:  I Dallan; L Bruschini; A Nacci; B Fattorp; A C Traino; F Rognini; G Ferraro; P Bruschini
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-02       Impact factor: 2.124

7.  Microperforations significantly enhance diffusion across round window membrane.

Authors:  Catherine M Kelso; Hirobumi Watanabe; Joseph M Wazen; Tizian Bucher; Zhen J Qian; Elizabeth S Olson; Jeffrey W Kysar; Anil K Lalwani
Journal:  Otol Neurotol       Date:  2015-04       Impact factor: 2.311

8.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

9.  Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.

Authors:  Emrah Kara; Fikret Cetik; Ozgür Tarkan; Ozgür Sürmelioğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-28       Impact factor: 2.503

10.  Is Intratympanic Dexamathasone Injection Effective for the Treatment of Idiopathic Sudden Sensorineural Hearing Loss?

Authors:  Kyu Ho Lee; Sung Hoon Ryu; Hyung Min Lee; Su Kyoung Park; Hyung-Jong Kim; Jiwon Chang
Journal:  J Audiol Otol       Date:  2015-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.